---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-295368"
form_type: "8-K"
ticker: "AURA"
cik: "0001501796"
company_name: "Aura Biosciences, Inc."
filed_at: "2022-11-30T23:59:59+00:00"
generated_at: "2026-06-21T11:37:28.421209+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aura Biosciences updates corporate presentation; no new material information disclosed

## Summary
- Aura Biosciences posted an updated corporate presentation for investor and analyst meetings as of November 30, 2022.
- The presentation update does not include any new financial results, clinical trial data, or material business changes.
- No specific numbers, dates, or events were provided in the filing text to analyze.

## SEC filing metadata
- accession: 0001193125-22-295368
- form_type: 8-K
- ticker: AURA
- cik: 0001501796
- company_name: Aura Biosciences, Inc.
- filed_at: 2022-11-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501796/000119312522295368/0001193125-22-295368-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501796/000119312522295368/d378294d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-295368
- JSON: https://secwatch.observer/filing/0001193125-22-295368.json
- Plain text: https://secwatch.observer/filing/0001193125-22-295368.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.